MedPath
HSA Approval

POLYGYNAX VAGINAL CAPSULE

SIN07745P

POLYGYNAX VAGINAL CAPSULE

POLYGYNAX VAGINAL CAPSULE

June 15, 1994

INDRUGCO PTE LTD

INDRUGCO PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantINDRUGCO PTE LTD
Licence HolderINDRUGCO PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

VAGINAL

Medical Information

A07AA51

neomycin, combinations

Manufacturer Information

INDRUGCO PTE LTD

Catalent France Beinheim SA

SWISS CAPS AG

Innothera Chouzy

Active Ingredients

POLYMYXIN B SULPHATE

35000 iu

Polymyxin B

NYSTATIN

100000 iu

Nystatin

NEOMYCIN SULPHATE

35000 iu

Neomycin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

POLYGYNAX VAGINAL CAPSULE - HSA Approval | MedPath